CDEK
← All drugs Report issue

surfactant

Recombinant proteinexperimental

Surfactants are chemical compounds that decrease the surface tension or interfacial tension between two liquids, a liquid and a gas, or a liquid and a solid. The word surfactant is a blend of "surface-active agent", coined in 1950. As they consist of a water-repellent and a water-attracting part, they are emulsifiers, enabling water and oil to mix. They can also form foam, and facilitate the detachment of dirt. — Wikipedia

Clinical trial activity

35 trials · 63 clinical orgs · 0 marketing orgs

Phase 1
8
Phase 2
15
Phase 3
8
Phase 4
8

Earliest trial started Jan 1, 1986 (NCT00000570)

Timeline

1980s

  1. Jan 1, 1986

    Earliest Phase 3 Sponsor(trial)

2000s

  1. Jan 1, 2005

    Earliest Phase 2 Sponsor(trial)

  2. Jan 1, 2006

    Earliest Phase 1 Sponsor(trial)

Indications

Approved for

Studied for

Mechanism of action

  • Unspecified targetSurfactant

    surfactant

Chemistry & pharmacology

Oral

No

Parenteral

No

Topical

No

Sources

Also known as

  • surfactant
  • surfactant
  • surfactants
  • surfactants

Clinical trials

NCT IDPhaseStart dateSponsor(s)
NCT06554522Phase 4Oct 1, 2024Aga Khan University, Indiana University, Open Philanthropy Project
NCT05898633Phase 1Dec 31, 2023Medical Research Council, University of London
NCT06074380Phase 4Nov 1, 2023University of Chicago
NCT05714865Phase 4Jun 25, 2023BLES Biochemicals Inc., Indiana University
NCT05534685N/ASep 20, 2022Government of Mexico, Instituto Mexicano del Seguro Social
NCT05000983Phase 1/Phase 2 (Phase 2)Oct 20, 2021Medline Industries, University of Manitoba
NCT04893863Phase 1/Phase 2 (Phase 2)Oct 1, 2021University of Manitoba
NCT04984057N/AAug 1, 2021Chongqing Medical University, People's Liberation Army of China
NCT04847375N/AApr 20, 2021Shahid Beheshti University of Medical Sciences
NCT04545866Phase 3Dec 31, 2020National Institute of Child Health and Human Development (NICHD), National Institutes of Health (NIH), University of Alabama, Birmingham
NCT03969992Phase 2Aug 1, 2019Aerogen
NCT03846960N/AApr 1, 2019Emek Medical Center, Technion University
NCT03959384Phase 3Jan 9, 2019University of Verona
NCT03217162N/AAug 1, 2017People's Liberation Army of China
NCT02985437Phase 1Nov 1, 2016European Research Council, University of Bremen
NCT02825953N/AJan 1, 2016Yuzuncu Yıl University
NCT02294630Phase 1/Phase 2 (Phase 2)Dec 1, 2014Wayne State University
NCT02337192Phase 1Jan 1, 2014University of Sao Paulo
NCT02091596Phase 2Oct 31, 2013Arkios BioDevelopment International, PluroGen Therapeutics
NCT02041546Phase 4Sep 1, 2013Zekai Tahir Burak Hospital
Showing 20 of 35 trials
Page 1 / 2

Organizations

Research & Development (63)

OrganizationOrg typeTrialsAs lead sponsorPhasesEarliest year
China Medical UniversityAcademic/Hospital3322004
Indiana UniversityAcademic/Hospital3222005
People's Liberation Army of ChinaGovernment3322012
University of California, San DiegoAcademic/Hospital3021986
National Heart, Lung, and Blood Institute (NHLBI)Government2111986
National Institute of Child Health and Human Development (NICHD)Government2212005
National Institutes of Health (NIH)Government2012005
Parion SciencesFor profit2212006
Technion UniversityAcademic/Hospital2022005
University of Alabama, BirminghamAcademic/Hospital2012005
University of ManitobaAcademic/Hospital2212021
Wayne State UniversityAcademic/Hospital2122005
AerogenFor profit1112019
Aga Khan UniversityAcademic/Hospital1012024
Arkios BioDevelopment InternationalFor profit1012013
BLES Biochemicals Inc.For profit1012023
Brown UniversityAcademic/Hospital1012005
Case Western Reserve UniversityAcademic/Hospital1012005
Cathay General HospitalAcademic/Hospital1012009
Chang Gung UniversityAcademic/Hospital1012009
63 organizations
Page 1 / 4